For research use only. Not for therapeutic Use.
Reutericyclin (Cat No.:I011456) is a natural compound belonging to the class of cyclic depsipeptides, which are produced by certain strains of lactic acid bacteria. It was first isolated from the bacteria Lactobacillus reuteri, and has since been found in other species of lactobacilli. Reutericyclin has been shown to have antimicrobial properties, particularly against various strains of gram-positive bacteria, including some that are known to cause infections in humans. It works by disrupting the bacterial cell membrane and inhibiting protein synthesis, leading to cell death. In addition, reutericyclin has also been studied for its potential therapeutic applications in various gastrointestinal disorders, such as inflammatory bowel disease and diarrhea, as well as for its ability to modulate the immune system and improve overall gut health.
Catalog Number | I011456 |
CAS Number | 303957-69-9 |
Synonyms | (R,E)-4-acetyl-1-(dec-2-enoyl)-5-hydroxy-2-isobutyl-1H-pyrrol-3(2H)-one |
Molecular Formula | C20H31NO4 |
Purity | ≥95% |
Target | Bacterial |
Solubility | Soluble in DMSO |
Storage | Store at -20°C |
IUPAC Name | (2R)-4-acetyl-1-[(E)-dec-2-enoyl]-3-hydroxy-2-(2-methylpropyl)-2H-pyrrol-5-one |
InChI | GNGSBVNLHSNSDF-LPQFERQCSA-N |
InChIKey | InChI=1S/C20H31NO4/c1-5-6-7-8-9-10-11-12-17(23)21-16(13-14(2)3)19(24)18(15(4)22)20(21)25/h11-12,14,16,24H,5-10,13H2,1-4H3/b12-11+/t16-/m1/s1 |
SMILES | CCCCCCC/C=C/C(=O)N1[C@@H](C(=C(C1=O)C(=O)C)O)CC(C)C |